Mineralys Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Mineralys Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Mineralys Therapeutics Inc
Rating: 1.39333325
Author: Trendlyne DVM scores

about

Mineralys Therapeutics Inc is a biopharmaceutical company focused on developing medicines to target diseases driven by dysregulated aldosterone. The Company's product candidate, lorundrostat, is a proprietary, orally administered, aldosterone synthas...

28.16 -0.33 (-1.16%)

40.90% Fall from 52W High

175.3K

XNAS Volume

XNAS 24 Apr, 2026 10:59 AM (EDT)

Not Eligible

Expensive Valuation

6.8 / 100

Technically Neutral

48.9 / 100

No estimates available

Mineralys Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Mineralys Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Mineralys Therapeutics Inc is a biopharmaceutical company focused on developing medicines to target diseases driven by dysregulated aldosterone. The Company's product candidate, lorundrostat, is a proprietary, orally administered, aldosterone synthas...

40.90% Fall from 52W High

SWOT Analysis

Mineralys Therapeutics Inc Live Price Chart